EP3744325
APPLICATION OF NOVEL TYROSINE KINASE INHIBITOR, ANLOTINIB, IN OSTEOSARCOMA AND CHONDROSARCOMA
:
EP einkaleyfi: Þýðing ekki lögð inn:
16.1.2019:
7.6.2023:
19740851.1
:
15.1.2039
:
APPLICATION OF NOVEL TYROSINE KINASE INHIBITOR, ANLOTINIB, IN OSTEOSARCOMA AND CHONDROSARCOMA
16.1.2019
7.6.2023
:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.:
No. 369 Yuzhou South Road, Lianyungang, Jiangsu 222062, CN
:
HUA, Yingqi:
Shanghai 200080, CN
:
WANG, Gangyang:
Shanghai 200080, CN
:
CAI, Zhengdong:
Shanghai 200080, CN
:
WANG, Zhuoying:
Shanghai 200080, CN
:
ZHANG, Tao:
Shanghai 200080, CN
:
WANG, Hongsheng:
Shanghai 200080, CN
:
SUN, Mengxiong:
Shanghai 200080, CN
:
WANG, Xunqiang:
Lianyungang, Jiangsu 222062, CN
:
ZHAN, Xiaole:
Lianyungang, Jiangsu 222062, CN
:
YANG, Zhaoqiang:
Lianyungang, Jiangsu 222062, CN
:
TU, Lifan:
Lianyungang, Jiangsu 222062, CN
:
LI, Pu:
Lianyungang, Jiangsu 222062, CN
:
201810058487:
22.1.2018:
CN
:
CN2019071846:
16.1.2019
:
A61K 31/4709, A61P 35/00, A61K 33/243, A61P 35/04